ARCHIVES

Report calls for stronger peer review, prioritization for cancer clinical trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 23 | June 10, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

NCI Supports New Cervical Cancer Screening Guideline

January 31, 2003

Two Studies Demonstrate Molecule Blocking Cell Damage

August 26, 2011

Also In This 12-page Issue: NCI To Cut Budgets For New Grants By 29 Percent. R01s To Be Funded At 11th Percentile.

February 3, 2006

“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism

April 17, 1981

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002